Next-Generation Proteomics at Scale

Arc Proteomics offers fully integrated mass spectrometry platforms and workflows to support unbiased large-scale discovery as well as specific and targeted analysis of proteins and their post-translational modifications (PTMs).

DISCOVERY PROTEOMICS SOLUTIONS: Explore the proteome in unprecedented depth and scale to identify novel insights into disease biology, drug mechanism of action and more.

TARGETED PROTEOMICS SOLUTIONS: Validate individual or panels of protein biomarkers to create high-throughput and robust assays that measure disease-related changes and drug effects.

Orbitrap Astral
Orbitrap Exploris™ 480

Platform and Workflows

Arc discovery and targeted proteomics approaches combine technical know-how, expertise and experience with the following platforms.


Detect and measure proteins and peptides in sample without any additives or labels (DDA or DIA)


Label proteins and peptides with unique isotopic amino acids or tags (e.g., TMT) to obtain precise quantitative measure across samples


Detect and quantify specific proteins and peptides using Parallel Reaction Monitoring (PRM) workflows

Arc Proteomics: Partnering to Advance Biomarker Discovery

Arc Proteomics is a cutting-edge proteomics company dedicated to advancing drug and biomarker discovery through its unique expertise and groundbreaking technologies.

Founded by proteomics experts, our company boasts a proven track record of forging impactful collaborations with leading academic institutions and biotechnology companies.

We specialize in developing and providing proteome-wide assays that measure proteins within cells, tissues and biofluids (e.g., plasma).

At Arc Proteomics, we’re committed to supporting your biomarker discovery endeavors. We offer comprehensive, customized solutions tailored to meet the specific requirements of your projects, ensuring that your research reaches its full potential.